In light of August being Psoriasis Awareness Month, we’re discussing treatment, causes, triggers, and management of this inflammatory disease common in children. Psoriasis is a skin disorder that ...
Please provide your email address to receive an email when new articles are posted on . PASI and static Physician Global Assessment scores significantly improved in pediatric patients with psoriasis ...
Please provide your email address to receive an email when new articles are posted on . Otezla is now available in the U.S. to treat children and adolescents with moderate to severe plaque psoriasis.
Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.
Credit: Arcutis Biotherapeutics. Zoryve is a once-daily, topical phosphodiesterase-4 (PDE4) inhibitor. The Food and Drug Administration (FDA) has approved Zoryve ® (roflumilast) cream 0.3% for the ...
The US FDA has approved guselkumab for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis (PsA) in children aged 6 years or older who weigh at least 40 kg, according ...
WESTLAKE VILLAGE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful ...
Health and Me on MSN
Study links throat infection to sudden skin inflammation, psoriasis
Common immune cells, neutrophils, are first responders to a strep throat infection, but also play a key role in the sudden ...
Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...
A common strep throat infection can trigger guttate psoriasis by altering the behavior of key immune cells, according to a ...
WESTLAKE VILLAGE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results